Skip to main content

IMMUTEP Ltd

IMMP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001506184

No open-market purchases or sales by IMMUTEP Ltd insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $692.0K in total; no superinvestor holds it.

Other share classesPRRUF

Q2 2023 vs. Q1 2023

How the institutions holding IMMUTEP Ltd changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of IMMP: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders1921+2
Shares2.96M1.62M−1.35M (−45.4%)
Value$4.95M$3.41M−$1.54M (−31.2%)

New holders (9)

Institutions that held IMMUTEP Ltd at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to IMMP in Q2 2023
InstitutionSharesValue% of portfolio
Meridian Wealth Management, LLC263,050$555.0K0.05%
Rhumbline Advisers25,863$54.6K0.00%
Two Sigma Investments, LP25,646$54.1K0.00%
UBS Group AG1,200$2.53K0.00%
Simplex Trading, LLC506$1.00K0.00%
Cutler Group LP600$1.00K0.00%
Advisor Group Holdings, Inc.55$1160.00%
JPMorgan Chase & Co2$40.00%
Ronald Blue Trust, Inc.60$00.00%

Sold out (7)

Institutions that held IMMUTEP Ltd at the end of Q1 2023 and filed for Q2 2023 without it.

Institutions that sold out of IMMP in Q2 2023
InstitutionShares, Q1 2023Value, Q1 2023
Old Mission Capital LLC16,441$27.6K
XY Capital Ltd13,949$23.4K
Envestnet Asset Management Inc22,606$13.5K
Belpointe Asset Management LLC3,000$5.04K
Group One Trading, L.P.2,748$4.62K
Royal Bank of Canada16$0
Tower Research Capital LLC (TRC)105$0